Small Molecules in Oncology

Nonfiction, Health & Well Being, Medical, Specialties, Oncology
Cover of the book Small Molecules in Oncology by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319914428
Publisher: Springer International Publishing Publication: August 1, 2018
Imprint: Springer Language: English
Author:
ISBN: 9783319914428
Publisher: Springer International Publishing
Publication: August 1, 2018
Imprint: Springer
Language: English

This book, written by respected experts, discusses in detail the latest developments in targeted oncology therapy using small molecules. It covers a wide range of small molecules, including tyrosine kinase inhibitors, mTOR, MEK, PARP, and multikinase inhibitors, as well as cell cycle and NTRK interacting agents. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. This book is the third edition of Small Molecules in Oncology, but has now been divided into two volumes, with the other volume focusing specifically on small molecules in hematology. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book, written by respected experts, discusses in detail the latest developments in targeted oncology therapy using small molecules. It covers a wide range of small molecules, including tyrosine kinase inhibitors, mTOR, MEK, PARP, and multikinase inhibitors, as well as cell cycle and NTRK interacting agents. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. This book is the third edition of Small Molecules in Oncology, but has now been divided into two volumes, with the other volume focusing specifically on small molecules in hematology. 

More books from Springer International Publishing

Cover of the book Security Standardisation Research by
Cover of the book Big Data Analytics in the Social and Ubiquitous Context by
Cover of the book Lords of the Ice Moons by
Cover of the book Computer Science – CACIC 2017 by
Cover of the book Fractional Dynamic Calculus and Fractional Dynamic Equations on Time Scales by
Cover of the book Principal Bundles by
Cover of the book Decision and Inhibitory Trees and Rules for Decision Tables with Many-valued Decisions by
Cover of the book Who’s to Blame for Greece? by
Cover of the book International Scholarships in Higher Education by
Cover of the book Near Threshold Computing by
Cover of the book Optimal Impulsive Control by
Cover of the book Microbiota of the Human Body by
Cover of the book Current Controversies in Cancer Care for the Surgeon by
Cover of the book An Introduction to Catalan Numbers by
Cover of the book The Body in Pain in Irish Literature and Culture by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy